BrainAurora Medical Technology Limited

SEHK:6681 Stock Report

Market Cap: HK$5.6b

BrainAurora Medical Technology Management

Management criteria checks 1/4

BrainAurora Medical Technology's CEO is Xiaoyi Wang, appointed in Jul 2023, has a tenure of 1.5 years. total yearly compensation is CN¥19.49M, comprised of 24.3% salary and 75.7% bonuses, including company stock and options. directly owns 11.25% of the company’s shares, worth HK$626.69M. The average tenure of the management team and the board of directors is 2.4 years and 1.5 years respectively.

Key information

Xiaoyi Wang

Chief executive officer

CN¥19.5m

Total compensation

CEO salary percentage24.3%
CEO tenure1.5yrs
CEO ownership11.2%
Management average tenure2.4yrs
Board average tenure1.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Xiaoyi Wang's remuneration changed compared to BrainAurora Medical Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥239m

Mar 31 2024n/an/a

-CN¥299m

Dec 31 2023CN¥19mCN¥5m

-CN¥359m

Dec 31 2022CN¥865kCN¥805k

-CN¥502m

Dec 31 2021CN¥679kCN¥648k

-CN¥698m

Compensation vs Market: Xiaoyi's total compensation ($USD2.66M) is above average for companies of similar size in the Hong Kong market ($USD471.00K).

Compensation vs Earnings: Xiaoyi's compensation has increased whilst the company is unprofitable.


CEO

Xiaoyi Wang (45 yo)

1.5yrs

Tenure

CN¥19,489,000

Compensation

He serves as Director at BrainAurora Medical Technology Limited since April 25, 2023. He serves as Executive Director at BrainAurora Medical Technology Limited since in July 2023. He serves as CEO and Chie...


Leadership Team

NamePositionTenureCompensationOwnership
Zheng Tan
Chief Strategy Officer & Chairman1.8yrsCN¥17.47m23.9%
HK$ 1.3b
Xiaoyi Wang
CEO, Chief Research Officer & Director1.5yrsCN¥19.49m11.25%
HK$ 626.7m
Junjie Wang
CFO & Joint Company Secretary3.3yrsno datano data
Longjun Cai
CTO & COO3yrsno datano data
Zhiyuan Lai
Vice President of Market & Operation3.3yrsno datano data
Ying Man Sham
Joint Company Secretary1.5yrsno datano data

2.4yrs

Average Tenure

40yo

Average Age

Experienced Management: 6681's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zheng Tan
Chief Strategy Officer & Chairman1.8yrsCN¥17.47m23.9%
HK$ 1.3b
Xiaoyi Wang
CEO, Chief Research Officer & Director3.3yrsCN¥19.49m11.25%
HK$ 626.7m
Feng Deng
Non-Executive Director1.5yrsno datano data
Yiu Por Lam
Independent Non-executive Directorno datano datano data
Yuezhong Li
Independent Non-executive Directorno datano datano data
Tao Duan
Independent Non-executive Directorno datano datano data
Sirui Li
Non-Executive Director1.8yrsno datano data
Mingqiu Li
Non-Executive Director1.5yrsno data9.76%
HK$ 543.5m

1.5yrs

Average Tenure

46yo

Average Age

Experienced Board: 6681's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 19:21
End of Day Share Price 2025/01/10 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BrainAurora Medical Technology Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution